Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Bimekizumab maintained efficacy responses through 52 weeks in biologic diseasemodifying antirheumatic drug-naive patients with psoriatic arthritis who were responders at week 16: results from be optimal, a phase 3, active-reference study

W. Tillett,J. F. Merola,Y. Tanaka,E. G. Favalli, D. Mcgonagle,J. A. Walsh,D. Thaci,B. Ink,R. Bajracharya,V. Taieb,C. T. Ritchlin

ANNALS OF THE RHEUMATIC DISEASES（2023）

Cited 0|Views11
No score
Key words
Psoriatic arthritis,Clinical trials
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined